Clearside Biomedical Inc at JMP Securities Life Sciences Conference Transcript
Good morning, everybody. Thanks for joining us. My name is John Walden, senior analyst here at JMP Securities and thanks for joining day two of our Life Sciences Conference. Pleased to be chatting with Clearside Biomedical and CEO, George Lasezkay. George, thanks for coming in and talking to us.
John, thanks for having us. Great to be here.
Questions & Answers
So it seems the suprachoroidal space is really gaining momentum in the past, let's say, two to three years. But can you remind folks what you guys are working on the suprachoroidal space, how it's differentiated -- we're seeing different companies play around in development programs, which I think is good news. You have an approval now. Can you talk a little bit about how the story has changed in the past two to three years and then we can jump into where you are today and moving forward.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
